Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
about
Concepts and clinical use of ultra-long basal insulinBrain glucose metabolism during hypoglycemia in type 1 diabetes: insights from functional and metabolic neuroimaging studiesDrug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysisHypoglycemia in Patients with Diabetes and Renal DiseaseRecovery of endocrine function after islet and pancreas transplantationAvoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetesMechanisms of hypoglycemia and exercise-associated autonomic dysfunctionClinical requirements for closed-loop control systems.Diabetes, insulin-mediated glucose metabolism and Sertoli/blood-testis barrier functionGlucose counterregulatory responses to hypoglycemia.Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes MellitusPreventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and CanadaPharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.Cognitive, behavioural and psychological barriers to the prevention of severe hypoglycaemia: A qualitative study of adults with type 1 diabetes.Insulin therapy and hypoglycemia.The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes.Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 DiabetesReal-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis.The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.Changing the treatment paradigm for type 2 diabetes.Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes ManagementHypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes.Self-reported frequency and impact of hypoglycemic events in Spain.Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies.Driving and diabetes: problems, licensing restrictions and recommendations for safe driving.Driving with diabetes in the future: in-vehicle medical monitoring.Hypoglycemia, diabetes, and cardiovascular events.Hypoglycemia in type 1 diabetes mellitus.American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trialA prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design.Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia.Incidence and predictors of hypoglycaemia in type 2 diabetes - an analysis of the prospective DiaRegis registry.The 5x1 DAFNE study protocol: a cluster randomised trial comparing a standard 5 day DAFNE course delivered over 1 week against DAFNE training delivered over 1 day a week for 5 consecutive weeksSelf-reported non-severe hypoglycaemic events in Europe.Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?Effect of hypoglycemia on brain structure in people with type 2 diabetes: epidemiological analysis of the ACCORD-MIND MRI trial.Associations of insulin resistance and adiponectin with mortality in women with breast cancer.
P2860
Q26770354-DE5298E3-1131-4651-A1A8-FE7E296FB498Q26777636-C9AB1261-8731-45DE-A485-4C2B3A23BDC3Q26784192-FB196FCC-A41B-47D0-AB1E-89283B8F4AA0Q26799515-1654B297-7DB0-450B-86E1-EB58CD85A68CQ26822596-605D7E14-D840-4D0D-BDB7-BF5B8DC07051Q26827955-EB0558B7-ED9E-4368-B896-F086E9ECCE39Q26860883-2E348A8C-EC30-4A8B-ABCC-1336F6DBA7B1Q27014883-AE434EB9-43A6-487B-9E18-A635F0C851FCQ27027422-ECB1B66A-886A-4D10-A4D7-27D78A5C7AA6Q27686872-CB3944C6-83BC-4B34-A7A7-CA51AA0B90F9Q27687851-E04153A1-E8AB-4D48-82C6-43B0B8E0D722Q28072980-63EA403F-16B2-4AB9-8ED7-5091CA6EA736Q28554260-D335BE25-08EE-49DC-A089-A111DA6E3F29Q30249371-8782BFEF-FA96-4530-A6E7-BFF5077CD9AFQ30361562-AD502BE5-C2FF-43AC-9DD9-6812EDF561B2Q30409109-E9E551F6-63E5-44D4-8108-0B1AF6BC68F4Q30985130-11A96DC8-9268-4CAB-8017-B10EF874B6D9Q31046934-3CE1E671-5B2A-48FA-8E31-3CFF28CDF0B8Q31121925-E0508E44-CA2B-4D5E-91FA-B39F57C9368AQ31149131-2AC162F6-6C18-49DD-BFE1-51EE9699F299Q33579759-9CACD605-5571-434E-85A1-E9D6E7EFB378Q33610676-4DB5855B-4924-4356-9C3B-7E79F6777AE3Q33621582-C79B6968-D729-4BB7-800C-B4E54397A079Q33739048-5E89DDCF-EED1-45BC-85DB-CB19C65BE9A8Q33785123-03FE501D-0A66-4420-82D4-7EE0AF6983E3Q33786220-9DE11B02-F6BB-48BB-9972-454F6F5181CBQ33802157-715D2361-671B-42A1-848F-5895F00D8888Q33828290-18446B96-A4EF-45B4-B3F2-C8FAA325BE68Q33873251-A6356D36-2F8B-4463-B37E-89E55A9DAC57Q34072593-D8C6AF4D-8468-44E3-A964-BB4B6CB100DBQ34081331-10D59C10-BBF6-44DD-85DA-5297CBEF4DE2Q34151785-567F2D50-DBCB-4797-99AA-3B629FF3AC7BQ34315270-57C32900-F956-448F-B831-A06D0B97C499Q34374343-53935769-2F67-44D3-B843-3464910AB172Q34449517-09C3434B-9A29-4595-909A-44F4BC8C28A3Q34471008-D3188C94-E7E6-4CCA-AE8E-CC1177060EBEQ34516215-B932258F-BDED-426A-8BCA-B2D468511229Q34533154-4FC120B4-6447-4099-8B71-0B04C7298DD2Q34545326-A27C869D-E7BF-4811-B7BB-B068304BAF6EQ34662835-3F621992-D8AE-4457-BB69-B8723E16C8BE
P2860
Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
description
im April 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2007
@uk
name
Risk of hypoglycaemia in types ...... modalities and their duration
@en
Risk of hypoglycaemia in types ...... modalities and their duration
@nl
type
label
Risk of hypoglycaemia in types ...... modalities and their duration
@en
Risk of hypoglycaemia in types ...... modalities and their duration
@nl
prefLabel
Risk of hypoglycaemia in types ...... modalities and their duration
@en
Risk of hypoglycaemia in types ...... modalities and their duration
@nl
P1433
P1476
Risk of hypoglycaemia in types ...... modalities and their duration
@en
P2888
P304
P356
10.1007/S00125-007-0599-Y
P577
2007-04-06T00:00:00Z